At the Federal Bar Association’s annual qui tam conference in Washington, D.C. on Feb. 20, 2025, the Deputy Assistant Attorney General for the Department of Justice’s (DOJ) Commercial Litigation Branch, Michael Granston, said...more
2/24/2025
/ Compliance ,
Department of Justice (DOJ) ,
Enforcement Actions ,
False Claims Act (FCA) ,
Fraud ,
Government Agencies ,
Healthcare ,
Healthcare Fraud ,
International Trade ,
Regulatory Agenda ,
Trump Administration
In an unusual criminal prosecution, the Chesapeake Regional Medical Center (CRMC), a hospital in Chesapeake, Virginia, was indicted last week by a federal grand jury in Virginia for conspiring to defraud the United States and...more
1/21/2025
/ Compliance ,
Corporate Misconduct ,
Criminal Prosecution ,
Department of Justice (DOJ) ,
Fraud ,
Grand Juries ,
Health Care Providers ,
Healthcare ,
Healthcare Fraud ,
Hospital Privileges ,
Hospitals ,
Indictments ,
Medicare ,
Physicians ,
Principles for Business ,
Reimbursements ,
Unnecessary Medical Procedures
Compared with other issues, healthcare enforcement during President-elect Donald Trump’s upcoming second term has received little attention. When he takes office again on January 20, should industry actors like pharmaceutical...more
1/6/2025
/ Anti-Kickback Statute ,
Bad Actors ,
Centers for Medicare & Medicaid Services (CMS) ,
Clinical Laboratories ,
Coronavirus/COVID-19 ,
Department of Health and Human Services (HHS) ,
Department of Justice (DOJ) ,
Enforcement ,
Enforcement Actions ,
False Claims Act (FCA) ,
Healthcare ,
Healthcare Fraud ,
Hospitals ,
Pharmaceutical Industry ,
Presidential Nominations ,
Trump Administration